SCHEMBL7128084

SCHEMBL7128084

C[C](C)CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BTN3A1 O00481 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1085871 0.82 MAPT (0.33) BTN3A1
SCHEMBL2079864 0.80 — —
SCHEMBL1876097 0.77 BACE1 (0.31) —
SCHEMBL6070373 0.77 — —
SCHEMBL2163046 0.75 TSHR (0.40) BTN3A1
SCHEMBL9163997 0.75 BACE1 (0.30) —
SCHEMBL16519884 0.75 — —
SCHEMBL7748876 0.75 — —
SCHEMBL31502627 0.75 BTN3A1 (0.34) BTN3A1
SCHEMBL18073549 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0793656-B1 NOVEL BENZYL PYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2003-03-26 — — EP claimed
US-5763450-A BACTERICIDES; TREATMENT OF INFECTIOUS DISEASES HOFFMANN-LA ROCHE INC. (US) 1998-06-09 — — US claimed
EP-0793656-B1 NOVEL BENZYL PYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2003-03-26 — — EP disclosed
US-5763450-A BACTERICIDES; TREATMENT OF INFECTIOUS DISEASES HOFFMANN-LA ROCHE INC. (US) 1998-06-09 — — US disclosed
Send feedback